Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nitoff Limited is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This activity is concentrated under 1 distinct examiner and 1 distinct art unit. This suggests that the company's current active intellectual property is focused on a specific biological or pharmaceutical innovation that falls within a single specialized department. This concentration allows for a specialized approach but also means the company's immediate patent success is tied to a narrow administrative channel.
The busiest examiner for this portfolio is CHAO, ALLEN, who is assigned 1 pending office action. Because this 1 examiner handles the only active action, the company's current prosecution results are entirely dependent on this individual's review. Practitioners should tailor their approach to the specific requirements of the 1 art unit, as it currently represents the full extent of the company's active engagement with the patent office. Without other active matters to provide alternative perspectives, the strategy must be tailored to the specific preferences and historical rulings of this one official. The outcome of this 1 pending office action will be the primary indicator of the company's success in securing intellectual property within the biotechnology field.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHAO, ALLEN | 1 | 73.3% | +28.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284523 | HEAD LICE TREATMENT | CHAO, ALLEN | 49d overdue |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18284523 | HEAD LICE TREATMENT | CHAO, ALLEN | 1622 | §103 | Final Rejection | 49d overdue | Pending | Sep 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNitoff Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Allen Chao has the most, with 1 of Nitoff Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.